about
Targeted therapies in gastric cancer and future perspectives.CD9 Expression in Colorectal Carcinomas and Its Prognostic SignificanceCD63 and GLUT-1 Overexpression Could Predict a Poor Clinical Outcome in GIST: A Study of 54 Cases with Follow-Up.CD9 expression indicates a poor outcome in acute lymphoblastic leukemia.Immune Targeting of Tetraspanins Involved in Cell Invasion and Metastasis.CD9 Tetraspanin: A New Pathway for the Regulation of Inflammation?
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի մարտին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Novel CD9-targeted therapies in gastric cancer
@ast
Novel CD9-targeted therapies in gastric cancer
@en
Novel CD9-targeted therapies in gastric cancer
@nl
type
label
Novel CD9-targeted therapies in gastric cancer
@ast
Novel CD9-targeted therapies in gastric cancer
@en
Novel CD9-targeted therapies in gastric cancer
@nl
prefLabel
Novel CD9-targeted therapies in gastric cancer
@ast
Novel CD9-targeted therapies in gastric cancer
@en
Novel CD9-targeted therapies in gastric cancer
@nl
P2093
P2860
P3181
P356
P1476
Novel CD9-targeted therapies in gastric cancer
@en
P2093
P2860
P304
P3181
P356
10.3748/WJG.V21.I11.3206
P407
P577
2015-03-21T00:00:00Z